Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Ko Y, Paramsothy S, Yau Y, Leong RW, et al. Superior treatment persistence with ustekinumab in Crohn's disease and vedolizumab in ulcerative colitis compared with anti-TNF biological agents: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study. Aliment Pharmacol Ther 2021 Jun 20. doi: 10.1111/apt.16436.
PMID: 34151447


Privacy Policy